Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing

被引:179
作者
Mengstie, Misganaw Asmamaw [1 ]
Wondimu, Belay Zawdie [2 ]
机构
[1] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Biomed Sci, Div Biochem, Debre Tabor, Ethiopia
[2] Jimma Univ, Inst Hlth, Dept Biomed Sci, Div Biochem, Jimma, Ethiopia
关键词
CRISPR; Cas-9; sgRNA; gene-editing; mechanism; applications; CRISPR/CAS9; CRISPR-CAS9; TALEN; GENE; CFTR;
D O I
10.2147/BTT.S326422
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clustered regularly interspaced short palindromic repeat (CRISPR) and their associated protein (Cas-9) is the most effective, efficient, and accurate method of genome editing tool in all living cells and utilized in many applied disciplines. Guide RNA (gRNA) and CRISPR-associated (Cas-9) proteins are the two essential components in CRISPR/Cas-9 system. The mechanism of CRISPR/Cas-9 genome editing contains three steps, recognition, cleavage, and repair. The designed sgRNA recognizes the target sequence in the gene of interest through a complementary base pair. While the Cas-9 nuclease makes double-stranded breaks at a site 3 base pair upstream to protospacer adjacent motif, then the double-stranded break is repaired by either non-homologous end joining or homology-directed repair cellular mechanisms. The CRISPR/Cas-9 genome-editing tool has a wide number of applications in many areas including medicine, agriculture, and biotechnology. In agriculture, it could help in the design of new grains to improve their nutritional value. In medicine, it is being investigated for cancers, HIV, and gene therapy such as sickle cell disease, cystic fibrosis, and Duchenne muscular dystrophy. The technology is also being utilized in the regulation of specific genes through the advanced modification of Cas-9 protein. However, immunogenicity, effective delivery systems, off-target effect, and ethical issues have been the major barriers to extend the technology in clinical applications. Although CRISPR/Cas-9 becomes a new era in molecular biology and has countless roles ranging from basic molecular researches to clinical applications, there are still challenges to rub in the practical applications and various improvements are needed to overcome obstacles.
引用
收藏
页码:353 / 361
页数:9
相关论文
共 75 条
  • [31] History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology
    Ishino, Yoshizumi
    Krupovic, Mart
    Forterre, Patrick
    [J]. JOURNAL OF BACTERIOLOGY, 2018, 200 (07)
  • [32] The genetic basis of disease
    Jackson, Maria
    Marks, Leah
    May, Gerhard H. W.
    Wilson, Joanna B.
    [J]. UNDERSTANDING BIOCHEMISTRY 4, 2018, 62 (05): : 643 - 723
  • [33] CRISPR-Cas9 Structures and Mechanisms
    Jiang, Fuguo
    Doudna, Jennifer A.
    [J]. ANNUAL REVIEW OF BIOPHYSICS, VOL 46, 2017, 46 : 505 - 529
  • [34] A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
    Jinek, Martin
    Chylinski, Krzysztof
    Fonfara, Ines
    Hauer, Michael
    Doudna, Jennifer A.
    Charpentier, Emmanuelle
    [J]. SCIENCE, 2012, 337 (6096) : 816 - 821
  • [35] CRISPR-Cas9 DNA Base-Editing and Prime-Editing
    Kantor, Ariel
    McClements, Michelle E.
    MacLaren, Robert E.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 22
  • [36] Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases
    Kotagama, Odatha W.
    Jayasinghe, Chanika D.
    Abeysinghe, Thelma
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [37] Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
    Li, Hongmei Lisa
    Fujimoto, Naoko
    Sasakawa, Noriko
    Shirai, Saya
    Ohkame, Tokiko
    Sakuma, Tetsushi
    Tanaka, Michihiro
    Amano, Naoki
    Watanabe, Akira
    Sakurai, Hidetoshi
    Yamamoto, Takashi
    Yamanaka, Shinya
    Hotta, Akitsu
    [J]. STEM CELL REPORTS, 2015, 4 (01): : 143 - 154
  • [38] Delivering CRISPR: a review of the challenges and approaches
    Lino, Christopher A.
    Harper, Jason C.
    Carney, James P.
    Timlin, Jerilyn A.
    [J]. DRUG DELIVERY, 2018, 25 (01) : 1234 - 1257
  • [39] Methodologies for Improving HDR Efficiency
    Liu, Mingjie
    Rehman, Saad
    Tang, Xidian
    Gu, Kui
    Fan, Qinlei
    Chen, Dekun
    Ma, Wentao
    [J]. FRONTIERS IN GENETICS, 2019, 9
  • [40] Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering
    Liu, Qiong
    Zhang, Hongxia
    Huang, Xiaotian
    [J]. FEBS JOURNAL, 2020, 287 (04) : 626 - 644